Moneycontrol PRO
you are here: HomeNewsAbbott india
abbott india
Jump to
104 Results Found
  • 14 more drug majors get HC relief from Centre ban on FDC meds Mar 17, 2016 07:00 PM IST

    14 more drug majors get HC relief from Centre ban on FDC meds

    The 22 healthcare companies have sought quashing of the government's March 10 notification banning over 300 FDC drugs, including cough syrup compositions on the ground that they involve "risk" to humans and safer alternatives were available.

  • FDC ban not done in proper manner; large brands to suffer: Pros Mar 17, 2016 10:45 AM IST

    FDC ban not done in proper manner; large brands to suffer: Pros

    Kewal Handa, industry expert and former MD of Pfizer says that alongwith sales loss, companies will also have to bear brunt of inventory loss as the decision has been immediate.

  • Stocks that are likely to be in focus in today's trade Mar 17, 2016 08:31 AM IST

    Stocks that are likely to be in focus in today's trade

    Here are the stocks that are likely to be in focus in today's trade

  • Centre ban on FDCs: P&G, Glenmark, Reckitt too get HC relief Mar 16, 2016 07:12 PM IST

    Centre ban on FDCs: P&G, Glenmark, Reckitt too get HC relief

    Justice Rajiv Sahai Endlaw said "same orders" would be passed in respect of the five companies which also included Alembic Pharmaceuticals and Piramal Enterprises Ltd as was passed yesterday and day before in the case of pharma majors Pfizer, Abbott Healthcare and Macleods Pharmaceuticals.

  • Stocks in news: Wipro, Adani Ent, Alok, Anuh Pharma, Cairn, NCC Mar 16, 2016 08:00 AM IST

    Stocks in news: Wipro, Adani Ent, Alok, Anuh Pharma, Cairn, NCC

    Wipro | Adani Enterprises | Alphageo India | A2Z Infra | Alok Industries | Anuh Pharma | Reliance Capital | NCC | Thomas Cook | Sunflag Iron & Steel | Gulf Oil International | Cairn India | GVK Power and NTPC are stocks, which are in the news today.

  • Delhi HC stays ban on 344 drugs; interim relief for pharma cos Mar 15, 2016 07:46 PM IST

    Delhi HC stays ban on 344 drugs; interim relief for pharma cos

    The Delhi HC has asked the government to explain its position and actions of issuing the March 10 notification. It has also stayed the notification with respect to Abbott and MacLeod and the stay will be in operation until next hearing on March 21.

  • Aim is to prevent rampant use of antibiotics: P Lilladher Mar 14, 2016 09:18 AM IST

    Aim is to prevent rampant use of antibiotics: P Lilladher

    Hailing the government's move, Surajit Pal, pharma analyst at Prabhudas Lilladher, says the aim of regulation is to prevent rampant use of antibiotics. He says Abbott is likely to be severely impacted by the move as it has around 15.4 percent exposure to fixed-dosed combinations.

  • Here's why pharma, telecom and bank stocks are in focus Mar 14, 2016 08:44 AM IST

    Here's why pharma, telecom and bank stocks are in focus

    Pharma companies such as Pfizer, Abbott, Glenmark and Wockhardt are likely to be in focus with the government banning over 300 drugs

  • Stocks in news: Coal India, Glenmark, Pfizer, GNFC, Cupid, Wipro Mar 14, 2016 08:01 AM IST

    Stocks in news: Coal India, Glenmark, Pfizer, GNFC, Cupid, Wipro

    Coal India | NMDC | Cupid | Rupa | Gujarat Narmada Valley Fertilizers | Jain Irrigation | NBCC | Tide Water Oil | Welspun Industries | Arvind Remedies | Gammon India | Pfizer | Abbott and Glenmark Pharma are stocks, which are in the news today.

  • Abbott India MD Rehan A Khan resigns Feb 29, 2016 04:16 PM IST

    Abbott India MD Rehan A Khan resigns

    "Rehan A Khan has vide his letter dated February 29, 2016, tendered resignation as the Managing Director and Director of the company to pursue career opportunity overseas," Abbott India said in a BSE filing.

  • Abbott India standalone Dec '15 sales at Rs 667.29 crore Feb 02, 2016 09:14 AM IST

    Abbott India standalone Dec '15 sales at Rs 667.29 crore

    Abbott India has reported a sales total income from operations of Rs 667.29 crore and a net profit of Rs 70.36 crore for the quarter ended Dec '15

  • Stocks in news: Tata Motors, Hero, Sun Pharma, Wipro, Aban, SBT Feb 02, 2016 08:20 AM IST

    Stocks in news: Tata Motors, Hero, Sun Pharma, Wipro, Aban, SBT

    Tata Motors | TVS Motor | DLF | Sun Pharma | Wipro | Tech Mahindra | Hero Motocorp | Balaji Telefilms | Maharashtra Seamless | Gujarat Siddhi | Shalimar Paints | EID Parry | Aban Offshore and State Bank Of Travancore are stocks, which are in the news today.

  • Abbott India Q3 net profit up 9% to Rs 70.36 cr Feb 01, 2016 09:08 PM IST

    Abbott India Q3 net profit up 9% to Rs 70.36 cr

    The company had posted a net profit of Rs 64.53 crore for the corresponding period of the previous fiscal, Abbott India said in a BSE filing.

  • Godrej Inds sells 2.01% stake in realty arm for Rs 132 cr Dec 22, 2015 07:58 PM IST

    Godrej Inds sells 2.01% stake in realty arm for Rs 132 cr

    The real estate firm is developing residential, commercial and township projects spread across 110.30 million sq ft in 12 cities across the country.

  • Abbott India Q2 net down 3% at Rs 61.70 cr Nov 07, 2015 01:50 PM IST

    Abbott India Q2 net down 3% at Rs 61.70 cr

    The company had posted a net profit of Rs 63.74 crore for the corresponding period of the previous fiscal, the drug firm said in a filing to BSE.

  • India battles big pharma over cough syrup abuse Oct 14, 2015 10:56 AM IST

    India battles big pharma over cough syrup abuse

    India's Cipla stopped making the product last year owing to regulatory demands, and US-based Abbott Laboratories and Pfizer have had to reduce batch sizes by up to half, cutting how much medicine their factories can produce.

  • Dr Reddy's Labs top pick, says Mehraboon Irani Oct 13, 2015 04:36 PM IST

    Dr Reddy's Labs top pick, says Mehraboon Irani

    Mehraboon Irani of Nirmal Bang Securities is of the view that Dr Reddy's Labs is the top pick.

  • Godrej Prop sells its BKC project for Rs 1,479cr to Abbott Sep 30, 2015 12:04 PM IST

    Godrej Prop sells its BKC project for Rs 1,479cr to Abbott

    The project was being developed for Jet Airways on a 50:50 profit-sharing agreement.

  • Porter Prize Recognizes the Strategic Acumen of Corporates in India Sep 28, 2015 01:16 PM IST

    Porter Prize Recognizes the Strategic Acumen of Corporates in India

    Highlights   Porter Prize is named after Michael E. ...

  • Godrej Prop to monetise BKC project; reduce debt: Sources Sep 16, 2015 12:28 PM IST

    Godrej Prop to monetise BKC project; reduce debt: Sources

    Godrej Properties is developing the BKC project for Jet Airways on a 50:50 sharing agreement.

  • Stocks in news: Maruti, Vedanta, Jet, Texmaco Rail, Alok Sep 15, 2015 08:16 AM IST

    Stocks in news: Maruti, Vedanta, Jet, Texmaco Rail, Alok

    Maruti Suzuki | Vedanta | Abbot India | Jet Airways | Nava Bharat Ventures | Tata Steel | Texmaco Rail | Alok Industries | Gujarat Gas and IL&FS Engineering are stocks, which are in the news today.

  • Abbott tangles with Indian regulators over syrup complaint Sep 14, 2015 09:22 AM IST

    Abbott tangles with Indian regulators over syrup complaint

    The previously unreported case underlines the weakness of India's unwieldy and poorly resourced drug and food regulatory system, the uncertainty it creates for foreign and domestic companies operating there and the potential risk to consumers.

  • Abbott India Q1 net up 35% at Rs 68.56 cr Aug 12, 2015 07:39 PM IST

    Abbott India Q1 net up 35% at Rs 68.56 cr

    The company had posted a net profit of Rs 50.93 crore for the same period of the previous fiscal, Abbott India said in a filing to BSE.

  • Positively biased in Dr Reddy's Labs: Mehraboon Irani Jul 30, 2015 04:43 PM IST

    Positively biased in Dr Reddy's Labs: Mehraboon Irani

    Mehraboon Irani of Nirmal Bang Securities is positively biased in Dr Reddy's Laboratories.

  • What took mighty Lupin down! Jul 24, 2015 03:46 PM IST

    What took mighty Lupin down!

    In an interview with CNBC-TV18‘s Sonia Shenoy & Latha Venkatesh, Praful Bohra, VP- Research, Religare said that Lupin‘s numbers are weak due to decline in the US business.

Sections
ISO 27001 - BSI Assurance Mark